Catalyst Funds Management Pty »

Revolution Medicines shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.8M 210k 46.70
2025-06-30 $1.7M 46k 36.79
2024-03-31 $271k 8.4k 32.23

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
Henderson Group
Wellington Management Company
Baker Bros. Advisors
FMR
BlackRock
Nextech Invest
Paradigm Biocapital Advisors
Bellevue Group
State Street Corporation
T. Rowe Price Investment Management
Alphabet
BVF
Deerfield Management Company

View all funds holding Revolution Medicines